The relative importance of large problems far away versus small problems closer to home: Insights into limiting the spread of antimicrobial resistance in England

BMC Medicine

Volumn 15, Issue 1, 2017, Pages

  Donker, Tjibbe ^a,b,c   Henderson, Katherine L ^c   Hopkins, Katie L ^a,c   Dodgson, Andrew R ^d,e   Thomas, Stephanie ^e   Crook, Derrick W ^a,b,c,f   Peto, Tim E A ^a,b,f   Johnson, Alan P ^a,c   Woodford, Neil ^a,c   Walker, A Sarah ^a,b,f   Robotham, Julie V ^a,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^e MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^f NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

Author keywords

Antimicrobial resistance; Carbapenemase producing enterobacteriaceae; Hospital network; Infection prevention and control; Regional coordination; Screening strategies

Indexed keywords

ANTIBIOTIC RESISTANCE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CLINICAL STUDY; COMPARATIVE EFFECTIVENESS; COORDINATION; ENGLAND; HOSPITAL; HUMAN; INFECTION PREVENTION; NATIONAL HEALTH SERVICE; NONHUMAN; PATIENT REFERRAL; PATIENT TRANSPORT; PREVALENCE; SCREENING; STATISTICS; ENTEROBACTERIACEAE INFECTIONS; HOSPITALIZATION; MASS SCREENING;

ANTIINFECTIVE AGENT;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; ENGLAND; ENTEROBACTERIACEAE INFECTIONS; HOSPITALIZATION; HOSPITALS; HUMANS; MASS SCREENING; PREVALENCE;

EID: 85018365291     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-017-0844-2     Document Type: Article

References (24)

1. Gopal Rao G, Michalczyk P, Nayeem N, Walker G, Wigmore L. Prevalence and risk factors for meticillin-resistant Staphylococcus aureus in adult emergency admissions - a case for screening all patients? J Hosp Infect. 2007;66:15-21.
2. European Centre for Disease Prevention and Control. Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE). Stockholm. 2011. http://ecdc.europa.eu/en/publications/Publications/110913_Risk_assessment_resistant_CPE.pdf. DOI: 10.2900/59034.
3. Donker T, Wallinga J, Grundmann H. Patient referral patterns and the spread of hospital-acquired infections through national health care networks. PLoS Comput Biol. 2010;6:e1000715.
4. Huang SS, Avery TR, Song Y, et al. Quantifying interhospital patient sharing as a mechanism for infectious disease spread. Infect Control Hosp Epidemiol. 2010;31:1160-9.
5. Smith DL, Levin SA, Laxminarayan R. Strategic interactions in multi-institutional epidemics of antibiotic resistance. Proc Natl Acad Sci U S A. 2005;102:3153-8.
6. Karkada UH, Adamic LA, Kahn JM, Iwashyna TJ. Limiting the spread of highly resistant hospital-acquired microorganisms via critical care transfers: a simulation study. Intensive Care Med. 2011;37:1633-40.
7. Simmering JE, Polgreen LA, Campbell DR, Cavanaugh JE, Polgreen PM. Hospital transfer network structure as a risk factor for Clostridium difficile infection. Infect Control Hosp Epidemiol. 2015;36(9):1031-7.
8. Donker T, Wallinga J, Slack R, Grundmann H. Hospital networks and the dispersal of hospital-acquired pathogens by patient transfer. PLoS One. 2012;7:e35002.
9. Ke W, Huang SS, Hudson LO, et al. Patient sharing and population genetic structure of methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A. 2012;109:6763-8.
10. Chang H-H, Dordel J, Donker T, et al. Identifying the effect of patient sharing on between-hospital genetic differentiation of methicillin-resistant Staphylococcus aureus. Genome Med. 2016;8:18.
11. Infection Prevention Working Party. WIP MRSA Guideline Hospitals. 2012. http://www.wip.nl/UK/free_content/Richtlijnen/MRSA. Accessed Mar 2016.
12. Public Health England. Carbapenemase-producing Enterobacteriaceae: early detection, management and control toolkit for acute trusts. 2014. https://www.gov.uk/government/publications/carbapenemase-producing-enterobacteriaceae-early-detection-management-and-control-toolkit-for-acute-trusts. Accessed Mar 2016.
13. Clauset A. Finding local community structure in networks. Phys Rev E. 2005;72:1-6.
14. Sheppard AE, Stoesser N, Wilson DJ, et al. Nested Russian Doll-like Genetic Mobility Drives Rapid Dissemination of the Carbapenem Resistance Gene bla_kpc. Antimicrob Agents Chemother. 2016;60:3767-78.
15. Woodford N, Zhang J, Warner M, et al. Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. J Antimicrob Chemother. 2008;62:1261-4.
16. Struelens MJ, Monnet DL, Magiorakos AP, Santos O'Connor F, Giesecke J. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro Surveill. 2010;15:1-10.
17. Scalia Tomba G, Wallinga J. A simple explanation for the low impact of border control as a countermeasure to the spread of an infectious disease. Math Biosci. 2008;214:70-2.
18. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med. 2001;344:1427-33.
19. Smith DL, Dushoff J, Perencevich EN, Harris AD, Levin SA. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc Natl Acad Sci U S A. 2004;101:3709-14.
20. Ciccolini M, Donker T, Grundmann H, Bonten MJM, Woolhouse MEJ. Efficient surveillance for healthcare-associated infections spreading between hospitals. Proc Natl Acad Sci U S A. 2014;111:2271-6.
21. Slayton RB, Toth D, Lee BY, et al. Estimated effects of a coordinated approach for action to reduce antibiotic-resistant infections in health care facilities. Morb Mortal Wkly Rep. 2015;64:826-31.
22. Schwaber MJ, Lev B, Israeli A, et al. Containment of a country-wide outbreak of carbapenem-resistant klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis. 2011;52:848-55.
23. Poole K, George R, Shryane T, et al. Evaluation of patient-held carbapenemase-producing Enterobacteriaceae (CPE) alert card. J Hosp Infect. 2016;92:102-5.
24. Venanzio V, Gharbi M, Moore LSP, et al. Screening suspected cases for carbapenemase-producing Enterobacteriaceae, inclusion criteria and demand. J Infect. 2015;71(4):493-5.